In May 2016, Chinese investment group Creat Group agreed to acquire UK-based Bio Products Laboratory for 820 million GBP (1.1 billion USD). Headquartered in Hertfordshire, Bio Products Laboratory is a plasma biotherapeutics company that provides therapeutics for conditions related to bleeding disorders, immune deficiencies and critical care. Creat will invest an additional 100 million GBP…
The Middle East is experiencing rising demand for high quality, innovative healthcare solutions. This is particularly true for the region’s largest healthcare market – Saudi Arabia. Saudi entities are increasingly willing to invest in healthcare companies overseas in order to source solutions and expertise that could meet the needs of the Saudi market. Healthcare is…
Investors based in the Middle East and regional healthcare companies having been actively seeking acquisitions and investment opportunities in the US. Overseas investments provide Middle Eastern individuals and institutions with a way to diversify their portfolios, rather than overexposing their operations to a single market, as noted recently in Forbes. According to Dhiraj Joshi, a…
Chinese investors specializing in healthcare are increasingly expanding into the European market with a series of high-profile, strategic investments. This is part of a trend of heightened healthcare deal activity from Chinese investors. Last year, companies based in China announced acquisitions in the medical industry worth 30.4 billion USD – representing twice the investment level…
Earlier this year, the pharmaceutical arm of Fosun International, a Chinese company with a market cap of over 13 billion USD, announced a1.3 billion USD buyout of India based Gland Pharma. Chinese companies are increasingly making healthcare deals abroad in order to become relevant and active players in the global healthcare market. The domestic market…
I-Bridge Capital, a health-care focused venture capital firm and incubator based in Shanghai, has announced the establishment of a joint venture with BioLineRx Ltd., a drug company based in Israel. The venture will incubate healthcare startups, in order to develop innovative clinical and pre-clinical therapeutic projects. Though these projects will originate primarily in Israel, they…
Last year, cyber attacks cost businesses an estimated 400 billion USD per year, according to British insurance company Lloyd’s. The estimate includes not only direct damage but also the disruption to business following the attack – because often, it is not the attack itself that causes the most damage, but its aftermath, which can drag on…
Today, an estimated two to five percent of global commerce takes place online. However, for many businesses, embracing the increasingly digital nature of business has been far more easily said than done. Businesses outside of the tech sector are often burdened with legacy systems and outdated methods of information processing. This results in a direct…
Europe will need between 670 and 780 billion USD worth of investments into its digital infrastructure if it hopes to keep pace with the United States and China. The region needs to develop fibre-optic networks and high-speed 5G wireless applications and networks in order to stay competitive in the global tech arena. According to Guenther…
Chinese investors are becoming increasingly interested in Europe, reports show. In the UK alone, Chinese investment into business and infrastructure has increased by nearly 500 percent over the past six years – from 666 million GBP in 2010 to 3.8 billion GBP in 2016. According to former Chancellor of the Exchequer, George Osborne, as many…